Evidence map›Paper›PMID 23721711›Full record

ArticleMicrovascular research2013

Protein phosphatase 2A activity is required for functional adherent junctions in endothelial cells.

Anita Kása, István Czikora, Alexander D Verin, Pál Gergely, Csilla Csortos

Open access · greenAbstract read
In one paragraph

Article in Microvascular research, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.8field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Role of protein phosphatase 2A in kidney disease (Review).Experimental and therapeutic medicine · 2021
    Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Low-Dose IL-2 in the Treatment of Lupus.Current rheumatology reports · 2016
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Anita KásaDepartment of Medical Chemistry, University of Debrecen Medical and Health Science Center, Debrecen H-4032, Egyetem tér 1., Hungary.
István Czikora
Alexander D Verin
Pál Gergely
Csilla Csortos
University of Debrecen · HUAugusta University Health · US

Funding

Therapeutic Mechanisms of RhoA Inhibition In Acute Lung InjuryP01HL101902 · NHLBI · AUGUSTA UNIVERSITY · PI BLACK, STEPHEN M · 2011 to 2016
$11.2M
Microtubules in lung endothelial cell barrier regulationR01HL067307 · NHLBI · UNIVERSITY OF CHICAGO · PI VERIN, ALEXANDER D · 2001 to 2009
$2.5M
NHLBI NIH HHS P01 HL101902NHLBI NIH HHS R01 HL067307
6 · The paper itself

Abstract

Reversible Ser/Thr phosphorylation of cytoskeletal and adherent junction (AJ) proteins has a critical role in the regulation of endothelial cell (EC) barrier function. We have demonstrated earlier that protein phosphatase 2A (PP2A) activity is important in EC barrier integrity. In the present work, macro- and microvascular EC were examined and we provided further evidence on the significance of PP2A in the maintenance of EC cytoskeleton and barrier function with special focus on the Bα (regulatory) subunit of PP2A. Immunofluorescent staining revealed that the inhibition of PP2A results in changes in the organization of EC cytoskeleton as microtubule dissolution and actin re-arrangement were detected. Depletion of Bα regulatory subunit of PP2A had similar effect on the cytoskeleton structure of the cells. Furthermore, transendothelial electric resistance measurements demonstrated significantly slower barrier recovery of Bα depleted EC after thrombin treatment. AJ proteins, VE-cadherin and β-catenin, were detected along with Bα in pull-down assay. Also, the inhibition of PP2A (by okadaic acid or fostriecin) or depletion of Bα caused β-catenin translocation from the membrane to the cytoplasm in parallel with its phosphorylation on Ser552. In conclusion, our data suggest that the A/Bα/C holoenzyme form of PP2A is essential in EC barrier integrity both in micro- and macrovascular EC.

Indexed as

Gene Expression Regulation, EnzymologicActinsAdherens JunctionsCell AdhesionCells, CulturedCytoplasmCytoskeletonEndothelial CellsHEK293 CellsHumansLungMicrocirculationPhosphorylationProtein Phosphatase 2Protein Structure, TertiaryPulmonary ArteryActinsProtein Phosphatase 2RNA, Small InterferingThrombin

Identifiers

PMID23721711
PMCPMC3758797
OpenAlexW2077950260

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.